Virax Biolabs Group Ltd - VRAX Net earnings per share for the last four quarters

Public company logo of Virax Biolabs Group Ltd (VRAX)

An optimized warehouse network in the US and Europe eliminates distribution disruptions for Virax Biolabs Group (VRAX). The annual EPS (TTM) growth trend visualizes this success, where 59.30 reflects the latest metric value. Efficiency is bolstered by an IT platform that increases distribution transparency, while revenue is based on bulk sales of diagnostic kits to public and private medical centers.

VRAX viraxbiolabs.com: Net earnings per share for the last 12 months in the range 02/11/2024 - 11/18/2026

VRAX (Virax Biolabs Group): analytical breakdowns and indicator data

- market price and analyst price targets:
Fundamental company valuation:VRAX - Virax Biolabs Group Ltd
Original product of Virax Biolabs Corp

This indicator tracks the annual dynamics of net income per share (GAAP/Non-GAAP) over a rolling twelve-month period. Steady growth on the EPS YoY ttm growth rate chart confirms the fundamental resilience of the business. Sharp declines signal a risk of overvalued quotes and the threat of margin calls. For Virax Biolabs Group (VRAX), this metric reflects the impact of geopolitical restrictions on test exports, as sanction barriers directly hinder the company's profits.

Direct competitors

A - Net earnings per share (EPS TTM)|Quest Corp (DGX) - Earnings per share for the last twelve months|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months exactsciences.com|revvity.com (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Net earnings per share (EPS TTM) Anbio Biotechnology Ltd (NNNN)|Sotera Health - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) QuidelOrtho Corp QDEL|OPK - Earnings per share for the last twelve months|Earnings per share for the trailing year CDNA (caredx.com)|MRVI: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Fulgent Genetics FLGT|LAB (Standard BioTools Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Cytek Biosciences, Inc.|Earnings per share for the last twelve months OraSure Technologies (OSUR)|XGN (Exagen) - Earnings per share for the trailing year|Earnings per share for the last twelve months MDxHealth MDXH|LUCD: Earnings per share for the last 12 months|PRE - Earnings per share for the last twelve months|Earnings per share for the trailing year IMDX (Insight Molecular Diagnostics Inc)|TRIB: Net earnings per share (EPS TTM)|prophaselabs.com - Earnings per share for the trailing year|Net earnings per share for the last 12 months AIMD|Co-Diagnostics Corp (CODX) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months HSCS (Heart Test Laboratories Inc.)|Net earnings per share for the last four quarters Biomerica Inc|Earnings per share for the last twelve months cardiodiagnosticsinc.com CDIO|ONCO: Earnings per share for the last 12 months|BJDX - Earnings per share for the last twelve months|Earnings per share for the trailing year AWH (Aspira Women's Health Inc.)|AXDX: Net earnings per share (EPS TTM)|CNTG - Net earnings per share for the last four quarters|ENZ (enzo.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|Net earnings per share for the last four quarters 23andMe Holding Co|Net earnings per share (EPS TTM) PMD (Psychemedics)